+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?



Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?



World Journal of Gastroenterology 13(15): 2145-2149



There are four steps in the interaction between intestinal microbes and mucosal inflammation in genetically predisposed individuals from the viewpoints of basic and clinical aspects of inflammatory bowel disease (IBD). The first step is an interaction between intestinal microbes or their components and intestinal epithelial cells via receptors, the second step an interaction between macrophages and dendritic cells and mucosal lymphocytes, the third step an interaction between lymphocytes and vascular endothelial cells, and the fourth step an interaction between lymphocytes and granulocytes producing proinflammatory cytokines or free radicals and mucosal damage and repair. Recent therapeutic approaches for IBD aim to block these four steps in the intestinal inflammation of patients with IBD.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055397437

Download citation: RISBibTeXText

PMID: 17465491


Related references

Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62(11): 1653-1664, 2013

Inflammatory bowel disease.Advances in diagnosis and treatment.1.Inflammatory bowel disease.Diagnosis and disease state.2.Basic examinations. Nihon Naika Gakkai Zasshi 82(5): 632-638, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.5.Simple intestinal ulcer. Nihon Naika Gakkai Zasshi 82(5): 679-682, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.10.Bacterial intestine infections. Nihon Naika Gakkai Zasshi 82(5): 701-707, 1993

Clinical disease activity and inflammatory activity in the rectum in relation to mucosal inflammation assessed by colonoscopy. A study of children and adolescents with chronic inflammatory bowel disease. Acta Paediatrica Scandinavica 79(5): 527-534, 1990

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.4.Intestinal Behcet's disease. Nihon Naika Gakkai Zasshi 82(5): 675-678, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.8.Entamebiasis coli. Nihon Naika Gakkai Zasshi 82(5): 693-696, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.9.Colitis aphthoid. Nihon Naika Gakkai Zasshi 82(5): 697-700, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.7.Pseudomembranous colitis. Nihon Naika Gakkai Zasshi 82(5): 688-692, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.6.Ischemic colitis. Nihon Naika Gakkai Zasshi 82(5): 683-687, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.3.Intestinal tuberculosis. Nihon Naika Gakkai Zasshi 82(5): 669-674, 1993

Inflammatory bowel disease.Advances in diagnosis and treatment.2.Origin and treatment of inflammatory bowel disease.2. Crohn's disease. Nihon Naika Gakkai Zasshi 82(5): 663-668, 1993

Advances in detection and management of dysplasia in inflammatory bowel disease: Is endoscopic submucosal dissection ready for prime time in inflammatory bowel disease?. Gastrointestinal Endoscopy 82(4): 739-741, 2015

Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome. Current Molecular Medicine 8(4): 258-273, 2008

Neuropharmacology of Stress-Induced Mucosal Inflammation: Implications for Inflammatory Bowel Disease and Irritable Bowel Syndrome. Current Molecular Medicine 8(4): 258-273, 2008